z-logo
open-access-imgOpen Access
Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults
Author(s) -
Glenson France,
Angela R. Wateska,
Mary Patricia Nowalk,
Jay V. DePasse,
Jonathan M. Raviotta,
Eunha Shim,
Richard K. Zimmerman,
Kenneth J. Smith
Publication year - 2018
Publication title -
innovation in aging
Language(s) - English
Resource type - Journals
ISSN - 2399-5300
DOI - 10.1093/geroni/igy035
Subject(s) - virology , medicine
Universal vaccine use in older persons could be either cost effective or cost saving when universal vaccine parameters are within plausible ranges. However, if its effectiveness is substantially less than current vaccines, its use would probably not be favored in geriatric populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom